ACTRN12609000056291尚未招募1 期
The effect of cancer progression on the activity of the liver enzyme called CYP2C19 in patients with carcinoma of the gastrointestinal tract using the probe drug proguanil.
niversity of Auckland0 个研究点目标入组 50 人开始时间: 2009年1月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Diagnosed with cancer
- •At least 18 years of age
- •Adequate renal and liver function
- •Serum creatinine =< 0.12 mg/L
- •Aspartate transaminase (AST), Alaninine transaminase (ALT) =< 2.0 X upper limit of normal (ULN) for institution
- •Alkaline phosphatase =< 2.5 X ULN
- •Total bilirubin =< ULN
- •Patients must be able to provide informed consent
排除标准
- •Patients receiving medication which is either a CYP2C19 inhibitor or inducer, and where a washout period is not clinically feasible
研究者
相似试验
招募中
不适用
A Study on the Effect of Cancer Treatment on the Cognitive Abilities of Cancer Patients Using Natural Language Processing Techniques for Spoken Languages -Monitoring cognitive function during the perioperative period and early after dischargeCancerJPRN-UMIN000039479Osaka International Cancer Insitute10
招募中
不适用
A Study on the Effect of Cancer Treatment on the Cognitive Abilities of Cancer Patients Using Natural Language Processing Techniques for Spoken LanguagesCancerJPRN-UMIN000033211Osaka International Cancer Insitute100
尚未招募
Unknown
An observational study for the impact of cancer treatment on diets and food preferences of advanced cancer patientsAdvanced solid cancerJPRN-UMIN000050541TT Medical Center Tokyo.300
进行中（未招募）
1 期
MOU-2017-01locally advanced resectable oesophago-gastric adenocarcinoma (Siewert I – III) with T3N0, T4N0, T2 – T4N+, stage Ib – IIIcMedDRA version: 21.0Level: PTClassification code 10030137Term: Oesophageal adenocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10001150Term: Adenocarcinoma gastricSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-001264-38-SKMasarykuv onkologický ústav70
进行中（未招募）
1 期
The change in PET and MRI measurements over time as a predictor for metastatic colorectal cancer outcome.Advanced colorectal cancer, refractory to all available medicationsMedDRA version: 18.1Level: PTClassification code 10010035Term: Colorectal cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.1Level: PTClassification code 10052358Term: Colorectal cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-006280-21-BEJules Bordet Institute53